SVALX
Price
$6.43
Change
-$0.01 (-0.16%)
Updated
Aug 14 closing price
Net Assets
8.65B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

SVALX vs VVIAX

Header iconSVALX vs VVIAX Comparison
Open Charts SVALX vs VVIAXBanner chart's image
Federated Hermes Strategic Value Div R6
Price$6.43
Change-$0.01 (-0.16%)
VolumeN/A
Net Assets8.65B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
SVALX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SVALX vs. VVIAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVALX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. SVALX (8.65B). SVALX pays higher dividends than VVIAX: SVALX (3.54) vs VVIAX (2.18). SVALX was incepted earlier than VVIAX: SVALX (9 years) vs VVIAX (25 years). SVALX (0.85) is less costly to investors than VVIAX (0.05). SVALX is a more actively managed with annual turnover of: 35.00 vs. VVIAX (9.00). SVALX has a lower initial minimum investment than VVIAX: SVALX (0) vs VVIAX (3000). SVALX annual gain was more profitable for investors over the last year : 11.51 vs. VVIAX (8.04). VVIAX return over 5 years is better than : 68.75 vs. SVALX (62.50).
SVALXVVIAXSVALX / VVIAX
Total Expense Ratio0.790.051,580%
Annual Report Gross Expense Ratio0.850.051,700%
Fund Existence9 years25 years-
Gain YTD10.8126.653163%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.65B196B4%
Annual Yield % from dividends3.542.18163%
Returns for 1 year11.518.04143%
Returns for 3 years14.9426.0957%
Returns for 5 years62.5068.7591%
Returns for 10 yearsN/A114.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXW20.820.36
+1.76%
CoreCivic
NBIX132.901.59
+1.21%
Neurocrine Biosciences
ZENV1.640.01
+0.49%
Zenvia
ATYR4.90-0.09
-1.80%
aTyr Pharma Inc
WNW1.69-0.05
-2.80%
Meiwu Technology Company Limited